174
|
Migration/Metastasis and Invasion
|
Hepatoblastoma
|
"" Parent
|
| | | | |
173
|
Metastasis/Vasculogenic Mimicry (VM) formation
|
Hepatoblastoma
|
"" Parent
|
| | | | |
172
|
VEGF-overexpressing cells
|
Hepatoblastoma
|
"" Parent
|
| | | | |
171
|
Endoplasmic Reticulum (ER) stress-induced apoptosis resistance (Tunicamycin-treated)
|
Hepatoblastoma
|
"" Parent
|
| | | | |
170
|
CD90+ (surface marker of liver cancer stem cells [LCSCs])
|
Hepatoblastoma
|
"" Parent
|
| | | | |
169
|
Doxorubicin treated cell (chronic dose)
|
Hepatoblastoma
|
"" Parent
|
| | | | |
168
|
circHMGCS1 expressing cells
|
Hepatoblastoma
|
"" Parent
|
| | | | |
167
|
Sliencing circHMGCS1
|
Hepatoblastoma
|
"" Parent
|
| | | | |
166
|
Silencing LncRNA OIP5-AS1
|
Hepatoblastoma
|
"" Parent
|
| | | | |
165
|
Silencing LncRNA LUCAT1
|
Hepatoblastoma
|
"" Parent
|
| | | | |
164
|
Silencing LncRNA H19
|
Hepatoblastoma
|
"" Parent
|
| | | | |
163
|
Silencing LncRNA NEAT1
|
Hepatoblastoma
|
"" Parent
|
| | | | |
162
|
LncRNA TUG-1 Overexpression
|
Hepatoblastoma
|
"" Parent
|
| | | | |
161
|
Metastatic HB/Agrresive C2 (gene-based system)/ CHIC High risk group
|
Hepatoblastoma
|
"" Parent
|
| | | | |
160
|
High Overall Survival
|
Hepatoblastoma
|
"" Parent
|
| | | | |
159
|
Embryonal Subtype
|
Hepatoblastoma
|
"" Parent
|
| | | | |
158
|
HBV (+)
|
Hepatoblastoma
|
"" Parent
|
| | | | |
157
|
Fetal Sbtype
|
Hepatoblastoma
|
"" Parent
|
| | | | |
156
|
Upregulated lncRNA TUG1
|
Hepatoblastoma
|
"" Parent
|
| | | | |
155
|
"" Parent
|
Hepatoblastoma
|
"" Parent
|
| | | | |